.Vaxcyte revealed what analysts called "sensational" stage 1/2 information for its 31-valent pneumoc...
.Recursion has stumbled with an early examination of its own tech-enabled approach to medicine explo...
.Contact it a case of good chemistry: Acepodia, a biotech based upon Nobel Champion scientific resea...
.Praxis Accuracy Medicines has racked up another midphase gain in epilepsy this year, with its sodiu...
.After escaping a professional grip many years back, Dyne Therapy has revealed brand-new phase 1/2 r...
.Arrowhead Pharmaceuticals has actually revealed its hand ahead of a possible showdown with Ionis, p...
.Pfizer and also Valneva may possess concerning 2 even more years to hang around before they produce...
.Let's study a conversation along with Ayla Ellison, Brutal Biotech Editor-in-Chief and also Michell...
.Bayer put on hold the stage 3 test for its own variable XIa inhibitor asundexian behind time last y...
.Sanofi is still bented on taking its numerous sclerosis (MS) med tolebrutinib to the FDA, executive...